Phasefocus contact:

/ Media contact:
Tracey Zimmermann,
+44(0)114 286 6377 / Jezz Leckenby, +44(0)7843 012997

The Francis Crick Institute selects the Phasefocus Livecyte label-free cell analysis system for their Light Microscopy facility.

Sheffield, UK, 13th June, 2017: Phasefocus provides a range of products and services based on its proprietary Ptychographic Quantitative Phase Imaging (QPI) technology to provide a wide range of analytical applications including label-free cell imaging and quantitative electron phase microscopy. Here, they report on the Light Microscopy Science Technology Platform at the Francis Crick Institute’s selection of the Livecyte label-free cell analysis system.

Dr Kurt Anderson heads up the Light Microscopy Science Technology Platform at the Francis Crick Institute. They specialise in high resolution, high throughput, fluorescence microscopy, three dimensional (3D) digital imaging, time-lapse and low-light-level imaging. The facility allows access to state-of-the-art equipment including single and multiphoton laser scanning confocals, spinning disc confocal, lightsheet and wide-field microscopes with deconvolution.

Dr Anderson leads a team in the development of light microscopy techniques and their applications in collaborative projects with several Crick research laboratories. These include the development of specialised imaging techniques, technology and data analysis. Live cell imaging is one of the areas of particular emphasis. With this in mind along with the aim to keep the facility up to date with the cutting-age imaging techniques, Dr Anderson has recently invested in the Livecyte label-free cell analysis from Phasefocus. Describing his decision and expectations for the system, Dr Anderson said “Research at the forefront is highly competitive, and our scientists are constantly on the lookout for something that will give them an edge. We were attracted to the Livecyte by the unique combination of innovative optics and powerful image analysis software.”

Dr Martin Humphry, CEO Phasefocus, commented “I’m delighted that the prestigious Francis Crick Institute has chosen Phasefocus to supply a Livecyte cell analysis system to be one of the first new instruments to be installed at their landmark new facility. We are looking forward to working with the scientists at the Institute and I’m excited about the potential of the Livecyte system for deepening understanding of the behaviour of live cells.”

Phasefocus sees the immense potential for the Livecyte technique and the wealth of information available to be unlocked. Livecyte enables quantitative label-free live cell analysis. With robust automatic tracking and behavioural analysis of hundreds of individual cells within heterogeneous cell populations, it is now possible to image without the need for intrusive dyes or labels. Unique

morphological, temporal, and dynamic phenotypic data make it simple to gain new biological insights and accelerate research.

For more information on ptychography and the Phasefocus Livecyte label-free kinetic cytometry system, please visit the Phasefocus web site: www.phasefocus.com/livecyte/.

Attachment:

Phasefocus’ Livecyte Cell Analysis System

at the Francis Crick Institute (© FTI Consulting)

About Phasefocus:

Phasefocus brings to multiple markets a range of products and services based on its proprietary Ptychographic Quantitative Phase Imaging (QPI) technology to provide a wide range of analytical applications including label-free cell imaging and analysis and quantitative electron phase microscopy.

Phasefocus’ label-free cell imaging and analysis tools offer researchers a revolutionary new ways to study cell morphology and dynamic behaviour at the individual cell level. They enable individual cells to be tracked, label-free, for hours and days with unprecedented robustness and accuracy.

About the Francis Crick Institute

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

For further information:

Please contact Phasefocus direct or their marketing agency, Talking Science:

Phase Focus Limited
Electric Works
Sheffield Digital Campus
Sheffield, S1 2BJ, UK
T +44(0)114 286 6377
M +44(0)7776 137841
www.phasefocus.com
/ Talking Science Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA, UK
T +44(0)1799 521881
M +44(0)7843 012997
www.talking-science.com